Overview

A Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of Telmisartan and Dapagliflozin.

Status:
Completed
Trial end date:
2023-11-09
Target enrollment:
Participant gender:
Summary
The study was designed to evaluate the safety and pharmacokinetic interaction between THP-00101 and THP-00102 in healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
THPharm Corp.
Treatments:
Dapagliflozin
Telmisartan